What causes pulsation in temperature (Temporal) artery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pulsation temperature in aluminum is not directly related to the provided medical evidence, but rather to thermal cycling during manufacturing or operational processes. When considering the medical context of pulsation, particularly in relation to temporal arteritis, the focus shifts to the clinical presentation and diagnosis of conditions like Giant Cell Arteritis (GCA).

Clinical Presentation

The clinical presentation of GCA can include symptoms such as headache, jaw claudication, limb claudication, and visual disturbances.

  • Key findings associated with a diagnosis of GCA, as identified in a systematic review and meta-analysis 1, include limb claudication, jaw claudication, temporal artery thickening, temporal artery loss of pulse, and elevated platelet count.
  • The presence of these symptoms and signs can guide the clinician towards a diagnosis of GCA, with temporal artery biopsy being a crucial diagnostic tool 1.

Diagnostic Approach

Temporal artery biopsy is conditionally recommended over temporal artery ultrasound for establishing a diagnosis of GCA, especially in settings where ultrasound expertise for this purpose is limited 1.

  • The recommendation for a long-segment temporal artery biopsy specimen (>1 cm) over a short-segment specimen (<1 cm) is based on the focal and segmental nature of GCA, aiming to increase the diagnostic yield 1.
  • Obtaining a temporal artery biopsy specimen within 2 weeks of starting oral glucocorticoids is conditionally recommended to maximize the likelihood of detecting histopathologic changes indicative of GCA 1.

Management and Outcome

The management of GCA involves the use of glucocorticoids, with the goal of reducing inflammation and preventing complications such as vision loss.

  • Early diagnosis and treatment are critical in improving outcomes and quality of life for patients with GCA.
  • The choice of diagnostic approach and the timing of biopsy in relation to the initiation of glucocorticoid therapy are important considerations in the management of suspected GCA, as highlighted by recent guidelines and systematic reviews 1.

From the Research

Pulsation Temp Al Causes

  • Temporal arteritis, also known as giant cell arteritis (GCA), is a systemic vasculitis that predominantly involves the temporal arteries 2, 3, 4, 5, 6
  • It is a medical emergency and should be treated promptly as it can lead to permanent loss of vision 2, 3, 5, 6
  • The disease is characterized by inflammation of medium and small extracranial vessels, which may result in ocular ischemia, aortitis, and peripheral limb ischemia 5
  • Classic symptoms of temporal arteritis include polymyalgia rheumatica, new-onset headache, jaw claudication, and visual symptoms such as diplopia and amaurosis fugax 6
  • Elevated erythrocyte sedimentation rate (ESR) is a common laboratory finding in temporal arteritis, but a normal ESR does not rule out the disease 2, 4
  • Temporal artery biopsy is the gold standard for diagnosis, but a negative biopsy does not exclude the disease 4, 5, 6

Diagnosis and Treatment

  • Patients with suspected temporal arteritis should be started on high-dose corticosteroid therapy without delay 3, 5, 6
  • A temporal artery biopsy should be performed after initiation of therapy to confirm the diagnosis 3, 5
  • Treatment may begin with high-dose oral prednisone in patients without visual or neurologic symptoms, and intravenous methylprednisolone sodium succinate should be given for patients with acute visual or neurologic signs or symptoms 3
  • The steroid dose should be tapered gradually over at least 1 year, with careful monitoring of the response both clinically and with serial inflammatory markers 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Giant Cell Arteritis.

Current treatment options in neurology, 2004

Research

Temporal arteritis.

Neurology. Clinical practice, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.